Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIVOT: Pandemic Influenza Vaccine in Organ Transplantation
NCT07240558Phase 3Active, not recruiting
- Sponsor
- University Health Network
- Start
- Nov 2025
- Primary completion
- Apr 2027
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in Avian Influenza (AI), pandemic influenza, sponsored by University Health Network. Started Nov 2025; status: active, not recruiting.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
Avian Influenza (AI)pandemic influenza
Beyond the preview
Go deeper on NCT07240558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240558.